针对H5N1的抗病毒策略:当前的选择和新兴的治疗方法
Cleo Anastassopoulou1, Antonios-Periklis Panagiotopoulos1, Kyriaki Ranellou1,2
1Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Athens, 11527, Greece.
Infection
|October 17, 2025
概括
高致病性禽流感A (H5N1) 构成了全球性的威胁. 本综述详细介绍了用于H5N1治疗和流行病准备的抗病毒药物,包括已批准和正在研究的药物.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 高致病性禽流感A ((H5N1) 由于其传播,高死亡率和动物感染潜力,对全球健康构成重大风险.
- 抗病毒治疗对于控制H5N1疫情和减少疾病严重程度至关重要,补充疫苗接种策略.
研究的目的:
- 提供针对H5N1.1病毒活动的抗病毒药物的全面概述.
- 详细介绍现有和新兴抗病毒药物的作用机制,批准状态,耐药性模式和疗效.
主要方法:
- 全球批准和区域授权的抗病毒药物的审查.
- 包括中国的研究药物和最近批准的化合物.
- 分析临床前数据,现有的临床试验结果和已识别的耐药性突变.
主要成果:
- 几种抗病毒药物在临床前模型中显示出对H5N1的活性.
- 最近在中国获得的监管批准突出显示了新的治疗选择.
- 尽管有前临床发现很有希望,但针对H5N1治疗的临床数据有限.
结论:
- 通过严格评估传统和新型化合物来扩大抗病毒武器库,对于疫情准备至关重要.
- 解决耐药性监测,治疗准入和监管协调方面的挑战对于有效应对H5N1疫情至关重要.
相关概念视频
Retrovirus Life Cycles
49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Viral Mutations
39.5K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.5K


